Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal transducer and activator of transcription 5A (STAT5A) is a member of the STAT family of transcription factors involved in transmitting signals from cytokines and growth factors to the cell nucleus, where it promotes gene transcription. STAT5A is activated by phosphorylation in response to cytokines like IL2, IL3, IL7, GM-CSF, erythropoietin, thrombopoietin, and growth hormones. It regulates key processes such as cell proliferation, survival, and differentiation, and plays a vital role in mammary gland development and immune cell function. STAT5A is implicated in the pathogenesis of several cancers, including leukemia, breast, prostate, and colorectal cancer, acting as both prognostic biomarker and therapeutic target, though most current STAT5 inhibitors do not distinguish between STAT5A and its closely related paralog STAT5B.
JAK-STAT pathway inhibition, often via Janus kinase inhibition leading to reduced STAT5A activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal transducer and activator of transcription 5A (STAT5A).